Matthew Shandy

Associate


mshandy@cooley.com

Matthew Shandy represents emerging companies and investors throughout the company lifecycle – from formation, through seed and later-stage financings, and liquidity events. He also provides clients with day-to-day advice on corporate governance and general legal matters.

Download full bio

Experience

  • Prevail Therapeutics $125 Million IPO 

  • Chainalysis Closes $30 Million Series B 

Education

  • University of Virginia School of Law
    JD, 2016

  • University of Oklahoma
    BA, Political Science
    2013


Admissions & Credentials

Virginia

Not admitted to practice in New York